Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (3y) (2014 - 2026)
Jazz Pharmaceuticals (JAZZ) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 62.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.22% |
| Dec 31, 2025 | 42.11% |
| Sep 30, 2025 | 158.05% |
| Jun 30, 2025 | -179.13% |
| Mar 31, 2025 | -162.98% |
| Dec 31, 2024 | 97.48% |
| Sep 30, 2024 | 85.06% |
| Jun 30, 2024 | 34.57% |
| Mar 31, 2024 | -28.31% |
| Dec 31, 2023 | -14.68% |
| Sep 30, 2023 | -4.63% |
| Jun 30, 2023 | -7.67% |
| Mar 31, 2023 | 33.75% |
| Dec 31, 2022 | -69.72% |
| Sep 30, 2022 | -29.06% |
| Jun 30, 2022 | -49.57% |
| Mar 31, 2022 | -60.38% |
| Dec 31, 2021 | -30.11% |
| Sep 30, 2021 | -32.50% |
| Jun 30, 2021 | -81.44% |